Moderna, Inc. (MRNA)

107,97 +1,79 (+1,69%) Al cierre: 04:00PM EDT

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 5600

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Stephane Bancel	CEO & Director	4,55M	300,71M	1973
Dr. Stephen Hoge M.D.	President	1,92M	N/A	1977
Mr. James M. Mock	Chief Financial Officer	1,4M	N/A	1977
Ms. Shannon Thyme Klinger	Chief Legal Officer & Corporate Secretary	1,39M	N/A	1971
Dr. Jerh Collins Ph.D.	Chief Technical Operations & Quality Officer	N/A	N/A	1967
Mr. Brad Miller	Chief Information Officer	N/A	N/A	1974
Ms. Lavina Talukdar CFA	Senior VP & Head of Investor Relations	N/A	N/A	N/A
Colleen Hussey	Senior Director of Corporate Communications	N/A	N/A	N/A
Ms. Tracey Franklin	Chief Human Resources Officer	N/A	N/A	1981
Dr. Melanie Ivarsson M.B.A., Ph.D.	Chief Development Officer	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Moderna, Inc., a día 1 de abril de 2024, es 10. Las puntuaciones base son Auditoría: 9; Tablero: 9; Derechos de los accionistas: 10; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.